Bioasis Technologies Inc.

BIOAF · OTC
Analyze with AI
2/28/2022
2/28/2021
2/28/2020
2/28/2019
Operating Activities
Net Income-$2,960$698-$4,056-$3,473
Dep. & Amort.$55$60$71$72
Deferred Tax-$1,424$872-$624$0
Stock-Based Comp.$441$279$566$980
Change in WC-$402-$248$692$568
Other Non-Cash$655$109$54-$1,377
Operating Cash Flow-$3,636$1,771-$3,299-$3,230
Investing Activities
PP&E Inv.$0$0$0-$2
Net Acquisitions$0$7$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$395
Investing Cash Flow$0$7$0$393
Financing Activities
Debt Repay.$2,530-$576$668$0
Stock Issued$196$192$1,205$3,527
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$90$696$1,825$0
Financing Cash Flow$2,636$312$2,493$3,527
Forex Effect-$6$70$22-$8
Net Chg. in Cash-$1,006$2,160-$784$682
Supplemental Information
Beg. Cash$2,737$576$1,360$678
End Cash$1,731$2,737$576$1,360
Free Cash Flow-$3,636$1,771-$3,299-$3,232
Bioasis Technologies Inc. (BIOAF) Financial Statements & Key Stats | AlphaPilot